Novo Integrated Sciences Inc Cash Flow Conversion Efficiency
Novo Integrated Sciences Inc cash flow conversion efficiency. Based on the latest financial reports, Novo Integrated Sciences Inc (NVOS) has a cash flow conversion efficiency ratio of -0.037x as of November 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-545.92K) by net assets ($14.61 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Novo Integrated Sciences Inc (2004–2024)
Cash flow conversion efficiency of Novo Integrated Sciences Inc from 2004 to 2024. This chart illustrates how Novo Integrated Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Novo Integrated Sciences Inc for real-time trading data and today's change.
Novo Integrated Sciences Inc Cash Flow Conversion Ratio Explained
Novo Integrated Sciences Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Novo Integrated Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Novo Integrated Sciences Inc ranked by their cash flow conversion efficiency. Also see Novo Integrated Sciences Inc stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Crimson Tide plc
LSE:TIDE
|
-0.014x |
|
Stardust Power Inc.
NASDAQ:SDST
|
0.235x |
|
Visionary Education Technology Holdings Group Inc.
NASDAQ:GV
|
-0.351x |
|
abrdn Property Income Trust Ltd.
LSE:API
|
0.916x |
|
Transense Technologies PLC
LSE:TRT
|
0.056x |
|
Eneraqua Technologies PLC
LSE:ETP
|
0.014x |
|
Goldstone Resources Ltd
LSE:GRL
|
0.097x |
|
Dillistone Group PLC
LSE:DSG
|
-0.044x |
Annual Cash Flow Conversion Efficiency for Novo Integrated Sciences Inc (2004–2024)
The table below shows the annual cash flow conversion efficiency of Novo Integrated Sciences Inc from 2004 to 2024. Review NVOS free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-08-31 | $14.61 Million | $-2.24 Million | -0.154x | -67.64% |
| 2023-08-31 | $24.50 Million | $-2.24 Million | -0.092x | +30.86% |
| 2022-08-31 | $44.43 Million | $-5.88 Million | -0.132x | -466.11% |
| 2021-08-31 | $43.80 Million | $-1.02 Million | -0.023x | -56.63% |
| 2020-08-31 | $29.57 Million | $-441.69K | -0.015x | +53.60% |
| 2019-08-31 | $25.54 Million | $-822.27K | -0.032x | +99.40% |
| 2018-08-31 | $172.77K | $-934.50K | -5.409x | -2961.09% |
| 2017-08-31 | $-4.29 Million | $-810.69K | 0.189x | +1419.42% |
| 2016-09-30 | $-7.08 Million | $101.39K | -0.014x | +99.88% |
| 2016-08-31 | $14.75K | $-175.62K | -11.904x | -5235.68% |
| 2015-08-31 | $-625.67K | $-145.03K | 0.232x | -11.88% |
| 2014-08-31 | $-947.87K | $-249.32K | 0.263x | -40.10% |
| 2013-08-31 | $-797.36K | $-350.12K | 0.439x | +126.25% |
| 2012-08-31 | $-2.33 Million | $-451.84K | 0.194x | -81.37% |
| 2011-08-31 | $-1.49 Million | $-1.55 Million | 1.042x | +30.39% |
| 2010-08-31 | $-1.19 Million | $-951.79K | 0.799x | +273.71% |
| 2009-08-31 | $-1.44 Million | $-307.59K | 0.214x | -62.94% |
| 2008-08-31 | $-844.10K | $-486.89K | 0.577x | -62.45% |
| 2007-08-31 | $-296.61K | $-455.65K | 1.536x | +407.69% |
| 2006-08-31 | $-409.22K | $-123.83K | 0.303x | +21.80% |
| 2005-08-31 | $-305.08K | $-75.79K | 0.248x | 0.00% |
| 2004-08-31 | $-305.08K | $-75.79K | 0.248x | -- |
About Novo Integrated Sciences Inc
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary care and related wellness products and services in Canada. It operates in two segments, Healthcare Services and Product Sales. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, … Read more